David Kaye’s practice focuses on venture capital investors, emerging companies and investment banking firms. He advises venture capital firms in connection with their investments in technology and life science startups and has experience working with emerging companies on a variety of complex corporate matters from inception to exit. His practice includes equity and debt financings, mergers & acquisitions, public offerings with both domestic and foreign issuers and general corporate law.
Download full bio